Compositions and use of EPAS1 inhibitors
US8114983B2 · kind B2 · utility
4Cited by
0References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 2009 |
| Grant date | Feb 14, 2012 |
| Priority date | — |
| Expiry date | Jan 29, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to inhibitors of endothelial PAS domain protein 1 (EPAS1), and methods and compositions related to the EPAS1 inhibitors. In certain embodiments, the EPAS1 inhibitors include nucleic acids, such as for example siRNAs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.